FOXO1 is a forkhead transcription factor and primary target of insulin signaling that regulates metabolic homeostasis and oxidative stress responses 1. It binds insulin response elements (IRE) and related Daf-16 binding elements (DBE) with consensus sequences 5'-TT[G/A]TTTTG-3' and 5'-TT[G/A]TTTAC-3' respectively 1. FOXO1 activity is suppressed by insulin signaling 1. As a transcriptional regulator, FOXO1 controls glucose metabolism through multiple mechanisms: it promotes hepatic gluconeogenesis by activating G6PC1, PCK1, and IGFBP1 2, suppresses osteocalcin expression to increase glucose levels [UniProt summary], and regulates pancreatic beta cell glucose sensing [UniProt summary]. FOXO1 also regulates bone metabolism as a main controller of osteoblast numbers and bone mass [UniProt summary]. FOXO1 functions as a critical regulator of cell survival and death, acting downstream of CDK1, PKB/AKT1, and STK4/MST1 34, promoting neural cell death 3, and mediating autophagy induction during starvation or oxidative stress 5. In endothelial cells, FOXO1 regulates viability and apoptosis through transcriptional activation of CCL2 and BCL2L11 6. Recent studies demonstrate FOXO1's role in macrophage senescence prevention during aging 7 and hematopoietic stem cell self-renewal and engraftment 8, suggesting therapeutic potential in age-related and regenerative medicine applications.